We are live on ! Find out more
AIM

Acrospire Investment Management Portfolio holdings

AUM $33K
1-Year Est. Return 24.6%
This Fund
S&P 500
This Quarter Est. Return
+10.71%
1 Year Est. Return
+24.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$243M
AUM Growth
+$92.6M
Cap. Flow
+$78.7M
Cap. Flow %
32.4%
Top 10 Hldgs %
2.66%
Holding
2,710
New
740
Increased
896
Reduced
491
Closed
523

Sector Composition

Rank Sector Weight
1 Industrials 15.42%
2 Healthcare 13.76%
3 Financials 12.63%
4 Consumer Discretionary 11.69%
5 Technology 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDN icon
326
Radian Group
RDN
$4.87B
$212K 0.09%
11,775
+6,050
+106% +$90.8K
SGU icon
327
Star Group
SGU
$416M
$212K 0.09%
19,731
-5,602
-22% -$55.1K
DX
328
Dynex Capital
DX
$3.17B
$210K 0.09%
10,268
+1,369
+15% +$28.3K
GHDX
329
DELISTED
Genomic Health, Inc.
GHDX
$210K 0.09%
7,144
+5,300
+287% +$162K
RGC
330
DELISTED
Regal Entertainment Group
RGC
$210K 0.09%
+10,200
New +$226K
FOR icon
331
Forestar Group
FOR
$1.46B
$209K 0.09%
15,714
+8,164
+108% +$99.9K
TBHC
332
DELISTED
The Brand House Collective
TBHC
$209K 0.09%
+13,504
New +$189K
QHC
333
DELISTED
Quorum Health Corporation
QHC
$209K 0.09%
28,812
+24,312
+540% +$146K
ONTO icon
334
Onto Innovation
ONTO
$14.3B
$208K 0.09%
8,318
+4,649
+127% +$106K
WSM icon
335
Williams-Sonoma
WSM
$29.5B
$208K 0.09%
8,600
+5,000
+139% +$127K
CERN
336
DELISTED
Cerner Corp
CERN
$208K 0.09%
4,400
+1,800
+69% +$95.5K
JAZZ icon
337
Jazz Pharmaceuticals
JAZZ
$16.7B
$207K 0.09%
+1,900
New +$212K
RBBN icon
338
Ribbon Communications
RBBN
$367M
$207K 0.09%
32,839
-9,964
-23% -$65.5K
CSOD
339
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$207K 0.09%
4,900
+3,900
+390% +$155K
VRTX icon
340
Vertex Pharmaceuticals
VRTX
$133B
$206K 0.08%
2,800
+2,000
+250% +$163K
WIX icon
341
WIX.com
WIX
$2.61B
$206K 0.08%
4,628
+2,600
+128% +$117K
HOLX
342
DELISTED
Hologic
HOLX
$205K 0.08%
5,100
-200
-4% -$7.72K
IMO icon
343
Imperial Oil
IMO
$62.3B
$205K 0.08%
5,900
+5,600
+1,867% +$188K
WBA
344
DELISTED
Walgreens Boots Alliance
WBA
$205K 0.08%
2,472
+1,972
+394% +$163K
CVGI icon
345
Commercial Vehicle Group
CVGI
$134M
$204K 0.08%
36,911
-8,232
-18% -$43.7K
NWPX icon
346
NWPX Infrastructure Inc
NWPX
$1.1B
$204K 0.08%
+11,867
New +$183K
MGI
347
DELISTED
MoneyGram International, Inc. New
MGI
$204K 0.08%
17,258
+7,799
+82% +$72.9K
PRAH
348
DELISTED
PRA Health Sciences, Inc.
PRAH
$204K 0.08%
3,700
+1,800
+95% +$98.8K
APLP
349
DELISTED
Archrock Partners, L.P. Common Units representing Limited Partner Interests
APLP
$204K 0.08%
12,717
+3,417
+37% +$53.1K
ICLR icon
350
Icon
ICLR
$12.8B
$203K 0.08%
2,695
+495
+23% +$38.4K

Similar funds

Acrospire Investment Management's Q4 2016 Portfolio in Review

As of Q4 2016, Acrospire Investment Management held 2,710 positions worth $243M, up 62% from $150M the previous quarter. Its ten largest holdings account for 2.7% of the portfolio.

Acrospire Investment Management deployed $78.7M of net new capital in Q4 2016, opening 740 new positions and adding to 896 existing holdings. Its largest new stake was Nomad Foods: 85,322 shares worth $817K.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ennis, an estimated $492K trimmed.

  • Acrospire Investment Management's largest Q4 2016 buy was Nomad Foods: 85,322 shares worth $817K.
  • Acrospire Investment Management added most to Nu Skin in Q4 2016, an estimated $560K increase.
  • Acrospire Investment Management's biggest Q4 2016 reduction was Ennis, cutting an estimated $492K.
  • Acrospire Investment Management fully exited HMS Holdings Corp. in Q4 2016, selling an estimated $279K.
  • Acrospire Investment Management's ten largest holdings make up 2.7% of its $243M portfolio in Q4 2016.
  • Acrospire Investment Management opened 740 new positions and closed 523 in Q4 2016.
  • Acrospire Investment Management's portfolio value rose 62% quarter-over-quarter to $243M.

Based on Acrospire Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.